Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Barrett Esophagus-I: Introduction01:21

Barrett Esophagus-I: Introduction

380
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
380
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

509
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
509
Endoscopic Procedures I: Esophagogastroduodenoscopy01:29

Endoscopic Procedures I: Esophagogastroduodenoscopy

571
An Esophagogastroduodenoscopy (EGD) is a diagnostic procedure in which an endoscopist uses a flexible, lighted endoscope to visualize the upper gastrointestinal (GI) tract. The procedure includes visualizing the oropharynx, esophagus, stomach, and the first part of the small intestine, the duodenum.
During an EGD, the endoscope can be used to:
571
Upper GI Series: Barium Swallow01:24

Upper GI Series: Barium Swallow

1.2K
The Barium Swallow Study, or a Barium Esophagogram, is a diagnostic imaging method used to visualize the upper gastrointestinal (GI) tract, including the esophagus, stomach, and small intestine. It employs barium sulfate, a radiopaque contrast material, to provide clear images of the upper digestive system, helping to identify abnormalities, diseases, or structural issues.
Purpose and Procedure
Patients undergoing this procedure ingest a liquid containing barium sulfate with a chalky...
1.2K
Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

279
Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
279
Endoscopic Procedures III: Video Capsule Endoscopy01:28

Endoscopic Procedures III: Video Capsule Endoscopy

467
Capsule endoscopy, or wireless or video capsule endoscopy, is a diagnostic procedure for examining the entire gastrointestinal tract. Patients swallow a capsule about the size of a vitamin tablet. The capsule is equipped with a transmitter, a battery, an LED light source, and a color video camera to capture images throughout the gastrointestinal tract. This procedure is particularly useful for diagnosing conditions such as Crohn's disease, ulcerative colitis, tumors, polyps, ulcers,...
467

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Innovation and commercialization pathway in gastrointestinal endoscopy: a practical primer from American Society for Gastrointestinal Endoscopy.

Gastrointestinal endoscopy·2026
Same author

Biliary endoscopic drainage of septic ICU patients deemed emergent (BEDSIDE): a retrospective cohort study (2012-2022).

BMC gastroenterology·2026
Same author

VSIG10L is a major determinant of esophageal homeostasis and inherited predisposition to Barrett's esophagus.

Nature communications·2026
Same author

Durability of cryoballoon ablation for eradication of neoplastic Barrett's esophagus: a multicenter prospective cohort study (with video).

Gastrointestinal endoscopy·2025
Same author

Barrett's Esophagus: Emerging Insights and Treatment Advances.

Gastrointestinal endoscopy clinics of North America·2025
Same author

Nonendoscopic Detection of Barrett's Esophagus on Patients Without Gastroesophageal Reflux Disease Symptoms.

The American journal of gastroenterology·2025

Related Experiment Video

Updated: Nov 29, 2025

Diagnosis of Neoplasia in Barrett’s Esophagus using Vital-dye Enhanced Fluorescence Imaging
06:55

Diagnosis of Neoplasia in Barrett’s Esophagus using Vital-dye Enhanced Fluorescence Imaging

Published on: May 11, 2014

12.3K

Progress in Screening for Barrett's Esophagus: Beyond Standard Upper Endoscopy.

Wei Keith Tan1, Anamay N Sharma2, Amitabh Chak2

  • 1MRC Cancer Unit, University of Cambridge, Cambridge Biomedical Campus, Box 197, Cambridge CB2 0XZ, United Kingdom; Department of Gastroenterology, Addenbrookes Hospital, Cambridge University NHS Foundation Trust, Hills Road, Cambridge CB2 0QQ, United Kingdom; Department of Gastroenterology, Hinchingbrooke Hospital, North West Anglia Foundation Trust, Huntingdon, PE29 6NT, United Kingdom.

Gastrointestinal Endoscopy Clinics of North America
|November 20, 2020
PubMed
Summary

Screening for Barrett's esophagus (BE), a precursor to esophageal adenocarcinoma, is gaining interest due to rising incidence and poor prognosis. Advances in imaging and diagnostics offer new hope for early detection.

Keywords:
Barrett’s esophagusEsophageal adenocarcinomaScreening

More Related Videos

Author Spotlight: Advancing Biopsy Techniques with Transesophageal Ultrasound
04:35

Author Spotlight: Advancing Biopsy Techniques with Transesophageal Ultrasound

Published on: November 21, 2023

848
Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

1.3K

Related Experiment Videos

Last Updated: Nov 29, 2025

Diagnosis of Neoplasia in Barrett’s Esophagus using Vital-dye Enhanced Fluorescence Imaging
06:55

Diagnosis of Neoplasia in Barrett’s Esophagus using Vital-dye Enhanced Fluorescence Imaging

Published on: May 11, 2014

12.3K
Author Spotlight: Advancing Biopsy Techniques with Transesophageal Ultrasound
04:35

Author Spotlight: Advancing Biopsy Techniques with Transesophageal Ultrasound

Published on: November 21, 2023

848
Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

1.3K

Area of Science:

  • Gastroenterology and Oncology
  • Cancer Screening Technologies

Background:

  • Esophageal adenocarcinoma incidence has risen sharply in Western countries over 40 years.
  • Early detection of Barrett's esophagus (BE) is crucial due to the poor prognosis of advanced disease.

Purpose of the Study:

  • To review the rationale and methods for screening Barrett's esophagus (BE).
  • To identify at-risk populations for BE screening.
  • To explore future research directions in BE detection.

Main Methods:

  • Review of recent advancements in imaging modalities for BE detection.
  • Evaluation of novel esophageal cell-sampling devices.
  • Analysis of biomarker assays for BE diagnosis.

Main Results:

  • Significant developments in imaging and cell-sampling technologies are enhancing BE detection capabilities.
  • Biomarker assays show promise for improved diagnostic accuracy.
  • Targeting at-risk populations is key for effective screening strategies.

Conclusions:

  • Screening for BE is increasingly important given the rising rates of esophageal adenocarcinoma.
  • Technological advancements are paving the way for more effective early detection of BE.
  • Further research is needed to optimize screening protocols and identify high-risk individuals.